Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.

@article{Hua2016AssociationOV,
  title={Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.},
  author={Camille Hua and Lise Boussemart and Christine Mateus and {\'E}milie Routier and C{\'e}line Boutros and Hugo Cazenave and Roxane Viollet and Marina W K Thomas and S{\'e}verine Roy and Naima Benannoune and Gorana Tomasic and Jean – Charles Soria and St{\'e}phane Champiat and Matthieu Texier and Emilie Lanoy and Caroline Robert},
  journal={JAMA dermatology},
  year={2016},
  volume={152 1},
  pages={45-51}
}
IMPORTANCE Vitiligo is an autoimmune skin disorder that reacts against melanocytes. The association of vitiligo with tumor response in patients with melanoma who undergo immunotherapy has been reported but is still controversial. OBJECTIVE To prospectively evaluate the appearance of vitiligo in patients receiving pembrolizumab, a monoclonal antibody directed against the programmed death cell receptor. DESIGN, SETTING, AND PARTICIPANTS This prospective observational study was conducted from… CONTINUE READING

From This Paper

Topics from this paper.
49 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Similar Papers

Loading similar papers…